キャリアスクリーニングの世界市場 (～2024年)：拡大キャリアスクリーニング (事前設計型・カスタム型)・標的疾患キャリアスクリーニング
Carrier Screening Market by Product and Service, Type (Expanded Carrier (Predesigned, Customized), Targeted Disease Carrier), Medical Condition (Pulmonary, Hematological), Technology (Sequencing, PCR), End User, Region - Global Forecast to 2024
|出版日||ページ情報||英文 149 Pages
|キャリアスクリーニングの世界市場 (～2024年)：拡大キャリアスクリーニング (事前設計型・カスタム型)・標的疾患キャリアスクリーニング Carrier Screening Market by Product and Service, Type (Expanded Carrier (Predesigned, Customized), Targeted Disease Carrier), Medical Condition (Pulmonary, Hematological), Technology (Sequencing, PCR), End User, Region - Global Forecast to 2024|
|出版日: 2019年11月14日||ページ情報: 英文 149 Pages||
世界のキャリアスクリーニングの市場は予測期間中17.5%のCAGR (年間複合成長率) で推移し、2019年の18億米ドルから、2024年には40億米ドルの規模に成長すると予測されています。病気の早期発見・予防への焦点拡大、染色体異常の高リスク性、技術の発展などの要因が同市場の成長を推進しています。
"Increasing emphasis on early disease detection and prevention is expected to drive the growth of the global carrier screening market."
The global carrier screening market size is expected to grow from USD 1.8 billion in 2019 to USD 4.0 billion by 2024, at a CAGR of 17.5% during the forecast period. Growth in the carrier screening market can primarily be attributed to factors such as increasing emphasis on early disease detection and prevention, the high risk of chromosomal abnormalities, and technological advancements in carrier screening, such as the introduction of expanded carrier screening panels. The increasing awareness of carrier screening is expected to provide a wide range of growth opportunities for players in the market.
On the basis of type, the carrier screening market is segmented into targeted disease screening and expanded carrier screening, which includes predesigned and customized carrier screening panel testing. The growth of this segment can be attributed to factors such as the increasing use of new high-throughput technologies such as sequencing & microarrays and recommendations for the use of expanded carrier screening.
On the basis of end user, the carrier screening market is segmented into hospitals, physician offices and clinics, reference laboratories, and other end users (blood banks, donor banks, community clinic laboratories, and non-profit organizations). In 2018, hospitals formed the largest end-user segment in the carrier screening market. Generally, gynecologists suggest couples to undergo carrier screening tests before and after pregnancy. In such cases, it is observed that gynecologists give reference for genetic counselors, who generally practice at hospitals. As a result, the awareness about hospital-based carrier screening tests is higher among patients than those offered at reference laboratories or at physician offices and clinics. Also, hospitals offer flexibility to patients in terms of sample collection, scheduling specimen pickups, and rapid turnaround time to produce results.
North America is expected to grow at the highest rate during the forecast period, followed by Europe. This growth can be attributed to several factors, such as the presence of well-established healthcare systems in the US and Canada, wide access to advanced screening techniques (such as DNA sequencing), recommendations for carrier screening, high and growing demand for the early detection of genetic disorders among the population, availability of mass genetic testing programs, increasing number of awareness campaigns, and the high incidence of chromosomal disorders.
In-depth interviews were conducted with chief executive officers (CEOs), marketing directors, other innovation and technology directors, and executives from various key organizations operating in the carrier screening market.
The carrier screening market comprises major players such as Illumina (US), Natera (US), Fulgent Genetics (US), Sema4 (US), Invitae (US), and LabCorp (US). The study includes an in-depth competitive analysis of these key players in the market, along with their company profiles, recent developments, and key market strategies.
The market study covers the carrier screening market across various segments. It aims at estimating the market size and the growth potential of this market across different segments based on the product & service, medical conditions, technology, condition, type, end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.
The report will help market leaders/new entrants in this market and provide information on the closest approximations of the revenue numbers for the overall carrier screening market and its subsegments. This report will help the stakeholders to understand the competitive landscape, to gain more insights to better position their businesses, and to plan suitable go-to-market strategies. The report will also help the stakeholders to understand the pulse of the market and provide information on key market drivers, restraints, opportunities, and challenges.
(Business Overview, Products/Services Offered, Recent Developments, and MnM View)*
Details on Business Overview, Products/Services Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.